Fedratinib
Fedratinib, sold under the brand name Inrebic, is an anti-cancer medication used to treat myeloproliferative diseases including myelofibrosis. It is used in the form of fedratinib hydrochloride capsules that are taken by mouth. It is a semi-selective inhibitor of Janus kinase 2 (JAK-2). It was approved by the FDA on 16 August 2019.
primaryTopic
Fedratinib
Fedratinib, sold under the brand name Inrebic, is an anti-cancer medication used to treat myeloproliferative diseases including myelofibrosis. It is used in the form of fedratinib hydrochloride capsules that are taken by mouth. It is a semi-selective inhibitor of Janus kinase 2 (JAK-2). It was approved by the FDA on 16 August 2019.
has abstract
Fedratinib, sold under the bra ...... s have been published in 2011.
@en
alternative name
Inrebic
@en
CAS number
936091-26-8
ChEBI
ChEMBL
class
DrugBank
FDA UNII code
6L1XP550I6
KEGG
PubChem
Link from a Wikipage to an external page
Wikipage page ID
33,860,916
page length (characters) of wiki page
Wikipage revision ID
1,015,031,475
Link from a Wikipage to another Wikipage
ATC prefix
L01
@en
ATC suffix
EJ02
@en
CAS number
ChEBI
ChEMBL
ChemSpiderID
17,626,393
class
DailyMedID
Inrebic
@en
density
DrugBank
DB12500
@en
IUPAC name
N-tert-Butyl-3-{5-methyl-2-[4--phenylamino]-pyrimidin-4-ylamino}-benzenesulfonamide
@en
KEGG
D10630
@en
legal EU
Rx-only
@en
legal US
Rx-only
@en
licence EU
yes
@en
PubChem
16,722,836
routes of administration
SMILES
CC1=CN=CNC3=CC=COCCN4CCCC4
@en
StdInChIKey
JOOXLOJCABQBSG-UHFFFAOYSA-N
@en
synonyms
SAR302503; TG101348
@en
tradename
Inrebic
@en
Verifiedfields
changed
@en
Watchedfields
changed
@en
wikiPageUsesTemplate
subject
comment
Fedratinib, sold under the bra ...... by the FDA on 16 August 2019.
@en